Ltd.Ī6: A Novel TCR Mimic Fully Human Antibodies Discovery Platform, Presented by Kaiqing Z., Biocytogen Pharmaceuticals (Beijing) Co. POSTER SESSION A - Monday, 14 November ~ In-Person, Verdi/VivaldiĪ1: Developability: Evaluating Multiple Parameters for Effective Lead Candidate Selection, Presented by Arron H., AbzenaĪ2: One Scaffold, Several Approaches: Tackling Cancer Diseases with Nanofitins, Presented by Mathieu C., AffilogicĪ3: Transferrin Receptor 1-Targeting Bicycles: A New Platform for Transcytosis, Presented by Haw L., Bicycle TherapeuticsĪ4: Is there a Real Solution for the Therapeutic mAbs Patent Cliff?, Presented by Paula GL., BioClonalĪ5: 1C3, a Differentiated Non-Blocking Agonist TNFR2 Antibody for Cancer Immunotherapy, Presented by Jie H., Biocytogen Pharmaceuticals (Beijing) Co. Poster Award Winners Announced Monday at 16:30, Tuesday at 16:45, and Wednesday at 14:30Īll posters are available on the virtual platform.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |